|
Market Closed -
Nasdaq
01:30:00 21/10/2026 am IST
|
5-day change | 1st Jan Change | ||
| 514.65 USD | +2.53% |
|
+6.07% | +13.52% |
| 15/10 | Goldman Sachs Adjusts Price Target on Vertex Pharmaceuticals to $654 From $653 | MT |
| 09/10 | Vertex Pharmaceuticals Says Alyftrek Delivers Pancreatic Function Recovery in Some Children | MT |
Chart: Technical Analysis
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| VRTX | Delayed | |
CBOE
| VRTX | Real-time | |
|
Tradegate
| VX1 | Real-time | |
|
Boerse Muenchen
| VX1 | Real-time | |
|
Xetra
| VX1 | Delayed | |
|
Borsa Italiana
| 1VRTX | End-of-day quote | |
|
Mexican S.E.
| VRTX * | End-of-day quote | |
|
Börse Stuttgart
| VX1 | Delayed | |
|
London S.E.
| 0QZU | Delayed | |
|
CBOE
| 0QZU | Real-time | |
|
Deutsche Boerse AG
| VX1 | Delayed | |
|
Wiener Boerse
| VRTX | End-of-day quote | |
|
CBOE
| Real-time | ||
Sao Paulo
| VRTX34 | Delayed | |
Buenos Aires S.E.
| VRTX | End-of-day quote | |
|
Buenos Aires S.E.
| VRTXD | End-of-day quote |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Neutral | Bullish |
| Resistance | 527.67 | 557.96 | 548.05 |
| Spread/Res. | -2.47% | -7.76% | -6.09% |
| Spread/Supp. | +6.07% | +21.60% | +7.87% |
| Support | 485.22 | 423.24 | 477.1 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- VRTX Stock
- Charts Vertex Pharmaceuticals Incorporated
Select your edition
All financial news and data tailored to specific country editions
